查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986581

美國製藥隔離器市場：市場規模、佔有率和趨勢分析（按產品和類型）、消費行為和競爭分析以及細分市場預測（2026-2033 年）

U.S. Pharmaceutical Isolators Market Size, Share & Trends Analysis Report By Product (Positive Pressure, Negative Pressure), By Type (Open Isolator, Closed Isolator), Consumer Behavior And Competitive Analysis, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國製藥隔離器市場概述

據估計，2025 年美國醫藥隔離器市值為 1.773 億美元，預計到 2033 年將達到 2.76 億美元，2026 年至 2033 年的複合年成長率為 5.9%。

美國製藥隔離器產業的驅動力是不斷增加的監管壓力，以確保藥品生產和分發過程中的高無菌性和工人安全。

針對危險藥品無菌處理和操作的更嚴格指導方針，醫療機構和生產商正被迫實施密封、嚴格控制的系統。另一個主要促進因素是生物製藥、細胞和基因療法以及高活性藥物的快速成長，這些藥物需要嚴格的環境控制。這些治療方法對污染高度敏感，且通常涉及危險物質，因此對先進的隔離解決方案的需求不斷成長。自動化消毒和模組化隔離器設計等技術進步也提高了設備的易用性和普及率。這些因素共同推動了已開發市場和新興市場對藥品隔離器的投資。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：美國製藥隔離器市場：影響因素、趨勢與範圍

  • 採用率和成長率預測：地圖
  • 產業價值鏈分析
  • 法律規範
  • 市場動態
  • 產業分析工具
    • 波特五力分析
    • 宏觀環境分析
  • 宏觀經濟趨勢分析

第4章：美國製藥隔離器市場：產品特定預測與趨勢分析

  • 波動分析及市場佔有率：按產品分類（2025-2033 年）
  • 美國製藥隔離器市場估算與預測：按產品分類（2021-2033 年）
  • 正壓
  • 負壓

第5章：美國製藥隔離器市場：按類型分類的估算和趨勢分析

  • 波動分析及市場佔有率：按類型分類（2025-2033 年）
  • 美國製藥隔離器市場估算與預測：按類型分類（2021-2033 年）
  • 開放式隔離器
  • 閉式隔離器

第6章：美國製藥隔離器市場：競爭格局

  • 近期趨勢及影響分析：依主要市場參與企業
  • 公司分類
  • 企業市場定位
  • 競爭對手儀錶板分析
  • 企業熱力圖分析（2025 年）
  • 策略規劃
    • 業務拓展
    • 企業合併（M&A）
    • 夥伴關係和聯盟
    • 新產品發布
  • 公司簡介
    • NuAire, Inc.
    • Germfree
    • Esco Micro Pte. Ltd.
    • Bioquell, An Ecolab Solution
    • Labconco
    • Howorth Air Technology Limited
    • Containment Technologies Group, Inc.
    • Terra Universal. Inc.
    • The Baker Company
    • Schaefer Technologies
Product Code: GVR-4-68039-540-4

U.S. Pharmaceutical Isolators Market Summary

The U.S. pharmaceutical isolators market size was estimated at USD 177.3 million in 2025 and is projected to reach USD 276.0 million by 2033, growing at a CAGR of 5.9% from 2026 to 2033. The U.S. pharmaceutical isolators industry is being driven by growing regulatory pressure to ensure higher sterility assurance and operator safety in drug manufacturing and compounding.

Stricter guidelines on aseptic processing and hazardous drug handling are pushing healthcare facilities and manufacturers to adopt closed, well-controlled systems. Another key driver is the rapid growth of biologics, cell and gene therapies, and high-potency drugs that require tightly controlled environments. These therapies are highly sensitive to contamination and often involve hazardous materials, increasing demand for advanced containment solutions. Technological improvements such as automated decontamination and modular isolator designs are also improving usability and adoption. Together, these factors are accelerating investment in pharmaceutical isolators across both developed and emerging markets.

U.S. Pharmaceutical Isolators Market Report Segmentation

This report forecasts revenue growth at the U.S. level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. pharmaceutical isolators market report based on product, type.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Positive Pressure
  • Negative Pressure
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Open Isolator
  • Closed Isolator

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Pharmaceutical Isolators Market Variables, Trends & Scope

  • 3.1. Concentration & Growth Prospect Mappin
  • 3.2. Industry Value Chain Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Market Challenge Analysis
    • 3.4.4. Market Opportunity Analysis
  • 3.5. Industry Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. Macro-environmental Analysis
  • 3.6. Economic Mega Trend Analysis

Chapter 4. U.S. Pharmaceutical Isolators Market: Product Estimates & Trend Analysis

  • 4.1. Product Movement Analysis & Market Share, 2025 & 2033
  • 4.2. U.S. Pharmaceutical Isolators Market Estimates & Forecast, By Product, 2021 to 2033 (USD Million)
  • 4.3. Positive Pressure
    • 4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4. Negative Pressure
    • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Pharmaceutical Isolators Market: Type Estimates & Trend Analysis

  • 5.1. Type Movement Analysis & Market Share, 2025 & 2033
  • 5.2. U.S. Pharmaceutical Isolators Market Estimates & Forecast, By Type, 2021 to 2033 (USD Million)
  • 5.3. Open Isolator
    • 5.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.4. Closed Isolator
    • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Pharmaceutical Isolators Market - Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Market Positioning
  • 6.4. Competitive Dashboard Analysis
  • 6.5. Company Heat Map Analysis, 2025
  • 6.6. Strategy Mapping
    • 6.6.1. Expansion
    • 6.6.2. Mergers & Acquisition
    • 6.6.3. Partnerships & Collaborations
    • 6.6.4. New Product Launches
  • 6.7. Company Profiles
    • 6.7.1. NuAire, Inc.
      • 6.7.1.1. Participant's overview
      • 6.7.1.2. Financial performance
      • 6.7.1.3. Product benchmarking
      • 6.7.1.4. Recent developments
    • 6.7.2. Germfree
      • 6.7.2.1. Participant's overview
      • 6.7.2.2. Financial performance
      • 6.7.2.3. Product benchmarking
      • 6.7.2.4. Recent developments
    • 6.7.3. Esco Micro Pte. Ltd.
      • 6.7.3.1. Participant's overview
      • 6.7.3.2. Financial performance
      • 6.7.3.3. Product benchmarking
      • 6.7.3.4. Recent developments
    • 6.7.4. Bioquell, An Ecolab Solution
      • 6.7.4.1. Participant's overview
      • 6.7.4.2. Financial performance
      • 6.7.4.3. Product benchmarking
      • 6.7.4.4. Recent developments
    • 6.7.5. Labconco
      • 6.7.5.1. Participant's overview
      • 6.7.5.2. Financial performance
      • 6.7.5.3. Product benchmarking
      • 6.7.5.4. Recent developments
    • 6.7.6. Howorth Air Technology Limited
      • 6.7.6.1. Participant's overview
      • 6.7.6.2. Financial performance
      • 6.7.6.3. Product benchmarking
      • 6.7.6.4. Recent developments
    • 6.7.7. Containment Technologies Group, Inc.
      • 6.7.7.1. Participant's overview
      • 6.7.7.2. Financial performance
      • 6.7.7.3. Product benchmarking
      • 6.7.7.4. Recent developments
    • 6.7.8. Terra Universal. Inc.
      • 6.7.8.1. Participant's overview
      • 6.7.8.2. Financial performance
      • 6.7.8.3. Product benchmarking
      • 6.7.8.4. Recent developments
    • 6.7.9. The Baker Company
      • 6.7.9.1. Participant's overview
      • 6.7.9.2. Financial performance
      • 6.7.9.3. Product benchmarking
      • 6.7.9.4. Recent developments
    • 6.7.10. Schaefer Technologies
      • 6.7.10.1. Participant's overview
      • 6.7.10.2. Financial performance
      • 6.7.10.3. Product benchmarking
      • 6.7.10.4. Recent developments

List of Tables

  • Table 1 U.S. pharmaceutical isolators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Table 2 U.S. pharmaceutical isolators market estimates and forecasts by product, 2021 - 2033 (USD Million)
  • Table 3 U.S. pharmaceutical isolators market estimates and forecasts by type, 2021 - 2033 (USD Million)
  • Table 4 Recent Developments & Impact Analysis, By Key Market Participants
  • Table 5 Company Heat Map Analysis, 2025

List of Figures

  • Fig. 1 Market Segmentation & Scope
  • Fig. 2 Information Procurement
  • Fig. 3 Data Analysis Models
  • Fig. 4 Market Formulation and Validation
  • Fig. 5 Data Validating & Publishing
  • Fig. 6 Market Snapshot
  • Fig. 7 Product Segment Snapshot
  • Fig. 8 Type Segment Snapshot
  • Fig. 9 Competitive Landscape Snapshot
  • Fig. 10 US Pharmaceutical Isolators Market Value, 2025 (USD Million)
  • Fig. 11 Market Concentration & Growth Prospect Mapping
  • Fig. 12 Value Chain Analysis
  • Fig. 13 U.S. Pharmaceutical Isolators Market: PORTER's Analysis
  • Fig. 14 U.S. Pharmaceutical Isolators Market: PESTEL Analysis
  • Fig. 15 U.S. Pharmaceutical Isolators Market, By Product: Key Takeaways
  • Fig. 16 U.S. Pharmaceutical Isolators Market: Product Movement Analysis & Market Share, 2025 & 2033
  • Fig. 17 U.S. Pharmaceutical Isolators Market Estimates and Forecasts, By Negative Pressure, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Pharmaceutical Isolators Market Estimates and Forecasts, By Positive Pressure, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Pharmaceutical Isolators Market, By Type: Key Takeaways
  • Fig. 20 U.S. Pharmaceutical Isolators Market: Type Movement Analysis & Market Share, 2025 & 2033
  • Fig. 21 U.S. Pharmaceutical Isolators Market Estimates and Forecasts, In Open Isolator, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Pharmaceutical Isolators Market Estimates and Forecasts, In Closed Isolator, 2021 - 2033 (USD Million)
  • Fig. 23 Key Company/Competition Categorization
  • Fig. 24 Competitive Dashboard Analysis
  • Fig. 25 Company Market Positioning
  • Fig. 26 Strategic Framework